History
The Charnwood Campus carries a huge legacy in pharmaceutical research and development.
The Charnwood Campus carries a huge legacy in pharmaceutical research and development.
Fisons (which dated back to the 1700s) . Fisons bought a part share in the then Loughborough-based company Genatosan, manufacturers of Sanatogen nerve tonic.
The significant discovery of INTAL, a fundamentally new approach to asthma therapy, was well under way during the 1950s and was marketed in 1968.
Construction of new research and manufacturing buildings was completed at Bakewell Road. The discovery and development of a second inhaled compound was subsequently marketed as TILADE. Other projects were started with significant compounds being discovered and also the discovery of DOPACARD.
Modernisation and expansion programme with the building of the pharmacology building.
Expansion with the building of the Biology and Chemistry facilities.
Fisons bought by Astra. Merged with Zeneca of Sweden to form Astrazeneca.
Charnwood Campus Formed.
Close cooperation with Charnwood Council, Leicester City Council, Medilink East Midlands, LLEP, Business Innovation & Skills, and Office for Life Sciences resulted in firming up Charnwood Campus Investment and Implementation Strategy.
First tenants on the campus
ARM
ARM specializes in developing truly cutting edge, next generation camera and display subsystems, bringing deep knowledge of human visual processing to create the best possible image quality and new user experiences.
Almac Group
Almac is a contract research organisation based in Craigavon, Northern Ireland. The company employs about 3,300 in the United Kingdom and United States. Almac provides integrated drug development services, research, and manufacturing to about 600 clients world-wide within diagnostics, sciences, clinical services, clinical technologies and pharmaceutical sectors. It was founded in 1968 as Galen by the late Sir Allen McClay.